01 January 2003
The increased number of CD4+CD28- T cells in patients after liver transplantation.
Andrzej Pawlik, Marcin Florczak, Marek Masiuk, Bogusław Machalinski, Marta Syczewska, Zbigniew Szych, Barbara Gawrońska-SzklarzAnn Transplant 2003; 8(2): 55-57 :: ID: 142802
Abstract
It has been observed that the organ manifestations in the patients withautoimmune diseases resulted from vessels damage may be caused by CD4+CD28- T lymphocytes, which expresshigh levels of IFN gamma and posses cytolytic activity. The increased number of these cells in the recipientsof allogenic bone marrow grafts and kidney grafts was also observed. The aim of the study was to evaluatethe amount of CD4+CD28- T lymphocytes in the recipients of allogenic liver grafts. The size of CD4+CD28-T cells compartment has been determined in 20 patients after liver transplantation and 20 healthy subjectsas control group using two-color FACS analysis. The frequency of CD4+CD28- T cells in the liver transplantrecipient was 5.65% and was significantly higher than in control group 1.4% (p < 0.001). The increasedlevel of cytotoxic CD4+CD28- T cells may be involved in vessels damage and gradual loss of graft function.
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






